Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,339,734
-$1,333,069 QoQ
Shares Held
9,855
-12.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#243
of 874 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,339,734 | 9,855 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,672,803 | 11,253 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,997,560 | 12,309 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,956,084 | 9,437 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,210,583 | 7,693 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,074,348 | 6,729 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,217,650 | 3,451 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,237,024 | 3,452 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,060,134 | 3,328 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $774,615 | 3,372 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,420,929 | 6,462 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,331,277 | 5,894 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,036,198 | 9,224 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,178,216 | 14,191 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $46,119,279 | 165,843 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $35,048,118 | 167,390 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $32,971,455 | 139,923 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $3,801,697 | 21,190 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,611,795 | 21,343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,778,113 | 15,051 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $560,835 | 3,126 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $516,362 | 3,087 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $335,304 | 2,209 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $178,164 | 1,764 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $317,504 | 2,624 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $248,833 | 2,624 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||